Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
106.81
-2.59 (-2.37%)
Nov 10, 2025, 12:21 PM EST - Market open
Teleflex Revenue
Teleflex had revenue of $913.02M in the quarter ending September 28, 2025, with 19.45% growth. This brings the company's revenue in the last twelve months to $3.19B, up 5.43% year-over-year. In the year 2024, Teleflex had annual revenue of $3.05B with 2.45% growth.
Revenue (ttm)
$3.19B
Revenue Growth
+5.43%
P/S Ratio
1.55
Revenue / Employee
$226,240
Employees
14,100
Market Cap
4.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 72.84M | 2.45% |
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TFX News
- 2 days ago - These Analysts Cut Their Forecasts On Teleflex Following Q3 Results - Benzinga
- 4 days ago - Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Teleflex Announces Quarterly Dividend - GlobeNewsWire
- 4 days ago - Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook - GlobeNewsWire
- 24 days ago - Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details - GlobeNewsWire
- 2 months ago - First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients - GlobeNewsWire
- 2 months ago - Teleflex Incorporated (TFX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire